1. Home
  2. NTHI vs INSG Comparison

NTHI vs INSG Comparison

Compare NTHI & INSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTHI
  • INSG
  • Stock Information
  • Founded
  • NTHI 2008
  • INSG 1996
  • Country
  • NTHI United States
  • INSG United States
  • Employees
  • NTHI N/A
  • INSG N/A
  • Industry
  • NTHI Biotechnology: Pharmaceutical Preparations
  • INSG Telecommunications Equipment
  • Sector
  • NTHI Health Care
  • INSG Telecommunications
  • Exchange
  • NTHI Nasdaq
  • INSG Nasdaq
  • Market Cap
  • NTHI 211.9M
  • INSG 237.1M
  • IPO Year
  • NTHI N/A
  • INSG 2000
  • Fundamental
  • Price
  • NTHI $9.80
  • INSG $16.64
  • Analyst Decision
  • NTHI
  • INSG Buy
  • Analyst Count
  • NTHI 0
  • INSG 3
  • Target Price
  • NTHI N/A
  • INSG $15.00
  • AVG Volume (30 Days)
  • NTHI 42.0K
  • INSG 357.0K
  • Earning Date
  • NTHI 11-19-2025
  • INSG 11-06-2025
  • Dividend Yield
  • NTHI N/A
  • INSG N/A
  • EPS Growth
  • NTHI N/A
  • INSG N/A
  • EPS
  • NTHI N/A
  • INSG 0.28
  • Revenue
  • NTHI $59,990.00
  • INSG $174,015,000.00
  • Revenue This Year
  • NTHI N/A
  • INSG N/A
  • Revenue Next Year
  • NTHI N/A
  • INSG $16.28
  • P/E Ratio
  • NTHI N/A
  • INSG $64.54
  • Revenue Growth
  • NTHI N/A
  • INSG 4.58
  • 52 Week Low
  • NTHI $3.20
  • INSG $6.24
  • 52 Week High
  • NTHI $25.00
  • INSG $19.75
  • Technical
  • Relative Strength Index (RSI)
  • NTHI N/A
  • INSG 63.17
  • Support Level
  • NTHI N/A
  • INSG $13.16
  • Resistance Level
  • NTHI N/A
  • INSG $16.35
  • Average True Range (ATR)
  • NTHI 0.00
  • INSG 1.04
  • MACD
  • NTHI 0.00
  • INSG 0.03
  • Stochastic Oscillator
  • NTHI 0.00
  • INSG 95.87

About NTHI NeOnc Technologies Holdings Inc. Common Stock

NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration (FDA).

About INSG Inseego Corp.

Inseego Corp is into the design and development of fixed and mobile wireless solutions (4G and 5G NR), Industrial Internet of Things and cloud solutions for enterprises, service providers, small and medium-sized businesses, governments, and consumers around the globe. Its products and services include intelligent mobile hotspots, wireless routers for IoT applications, USB modems, integrated telematics and mobile tracking devices, which are supported by applications software and cloud services designed to enable customers to easily analyze data insights and configure and manage their hardware. It generates maximum revenue from United States and Canada. The company also has a presence in Australia and Europe (including United Kingdom).

Share on Social Networks: